CONMED Corp
Closed
SectorHealthcare
35.21 4.45
Overview
Share price change
24h
Min
33.47
Max
35.64
Income | -2.9M 14M |
|---|---|
Sales | -56M 317M |
P/E Sector Avg | 18.384 50.958 |
EPS | 0.89 |
Dividend yield | 1.23 |
Profit margin | 4.362 |
Employees | 3,900 |
EBITDA | -17M 38M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +19.05% upside |
Dividend yield Sector Avg | 1.23% 2.41% |
|---|---|
Next Earnings | 29 Jul 2026 |
Market Cap | -188M 980M |
|---|---|
Previous open | 30.76 |
Previous close | 35.21 |
News Sentiment
By Acuity
50%
50%
146 / 342 Healthcare
CONMED Corp Chart
Past performance is not a reliable indicator of future results.
About CONMED Corp
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.